New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
Janelle J Juul, Caitlin F Mullins, William J Peppard, Angela M Huang Department of Pharmacy, Froedtert & the Medical College of Wisconsin, Milwaukee, WI, USA Abstract: Dalbavancin, an intravenous glycopeptide, was approved by the US Food and Drug Administration in May 2014 for use in adult patie...
保存先:
主要な著者: | Juul JJ (著者), Mullins CF (著者), Peppard WJ (著者), Huang AM (著者) |
---|---|
フォーマット: | 図書 |
出版事項: |
Dove Medical Press,
2016-02-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
著者:: Leuthner KD, 等
出版事項: (2016) -
Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in Pediatrics: Insights from Continuation Therapy Experience
著者:: Sara Maria Scarano, 等
出版事項: (2024) -
Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs
著者:: Pedro Luis Gonzalez, 等
出版事項: (2018) -
Dalbavancin in the treatment of skin and soft tissues infection
著者:: Ana Candela Fajardo, 等
出版事項: (2017) -
Acute bacterial skin and skin structure infections: current perspective
著者:: Megha Shah, 等
出版事項: (2011)